Journal
Theranostics
Publication Date
2020
Volume
10
Issue
17
First Page
7510
Last Page
7526
Document Type
Open Access Publication
DOI
10.7150/thno.44523
Rights and Permissions
Esser AK, Ross MH, Fontana F, Su X, Gabay A, Fox GC, Xu Y, Xiang J, Schmieder AH, Yang X, Cui G, Scott M, Achilefu S, Chauhan J, Fletcher S, Lanza GM, Weilbaecher KN. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer. Theranostics 2020; 10(17):7510-7526. doi:10.7150/thno.44523. Available from http://www.thno.org/v10p7510.htm This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Recommended Citation
Esser, Alison K.; Ross, Michael H.; Fontana, Francesca; Su, Xinming; Gabay, Ariel; Fox, Gregory C.; Xu, Yalin; Xiang, Jingyu; Schmieder, Anne H.; Yang, Xiaoxia; Cui, Grace; Scott, Michael; Achilefu, Samuel; Chauhan, Jay; Fletcher, Steven; Lanza, Gregory M.; and Weilbaecher, Katherine N., "Nanotherapy delivery of c-myc inhibitor targets protumor macrophages and preserves antitumor macrophages in breast cancer." Theranostics. 10, 17. 7510 - 7526. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9206